Haematological disorders

Applied filters

Haematological disorders

COVID-19 Medicines Optimisation (2)
- COVID-19 Medicines Optimisation: Specialty Guidance (1)
COVID-19 Vaccines (1)
- General information and guidance (1)
  - All vaccines: Answers to Questions (1)
Care Setting (3)
- Emergency medicine and urgent care (1)
- Trusts (3)
Events (1)
- Past Event (1)
- Webinars (1)
Guidance (91)
- Administering (3)
- Advanced therapy medicinal products (10)
- Cautions and contraindications (1)
- Dosing (4)
- Safety in Breastfeeding (51)
- Stability in dosette boxes (40)
- Stability outside the fridge (23)
- Supply (1)
Interest areas (2)
- Medicines Safety (2)
Medicine (116)
- Agalsidase alfa (1)
- Albumin human (1)
- Alfacalcidol (1)
- Alglucosidase alfa (1)
- Aluminium hydroxide (1)
- Anagrelide (1)
- Apixaban (2)
- Ascorbic acid (1)
- Calcitriol (1)
- Calcium acetate (1)
- Calcium carbonate (1)
- Calcium polystyrene sulfonate (1)
- Carglumic acid (1)
- Carnitine (1)
- Celiprolol (1)
- Cinacalcet (1)
- Colecalciferol (1)
- Cyanocobalamin (2)
- Dabigatran etexilate (2)
- Dalteparin (3)
- Darbepoetin alfa (1)
- Deferasirox (1)
- Deferiprone (1)
- Eculizumab (1)
- Edoxaban (1)
- Eftrenonacog alfa (1)
- Eltrombopag (1)
- Emicizumab (1)
- Enoxaparin (4)
- Epoetin alfa (2)
- Epoetin beta (2)
- Epoetin zeta (1)
- Ergocalciferol (1)
- Factor VIII + von Willebrand factor (1)
- Ferric carboxymaltose (1)
- Ferrous fumarate (1)
- Ferrous gluconate (1)
- Ferrous sulfate (1)
- Ferumoxytol (1)
- Fibrinogen (1)
- Fibrinogen + Thrombin (1)
- Filgrastim (1)
- Folic acid (1)
- Fostamatinib (1)
- Galsulfase (1)
- Haem arginate (1)
- Heparin (1)
- Hydroxocobalamin (3)
- Hydroxycarbamide (1)
- Idarucizumab (2)
- Idursulfase (1)
- Imiglucerase (1)
- Iron dextran (2)
- Iron isomaltoside 1000 (1)
- Iron sucrose (1)
- Lanthanum carbonate (1)
- Laronidase (1)
- Lenograstim (1)
- Lipegfilgrastim (1)
- Magnesium sulfate (1)
- Menadiol (1)
- Mercaptamine (1)
- Methoxy polyethylene glycol-epoetin beta (1)
- Miglustat (1)
- Nicotinamide (1)
- Nitisinone (1)
- Octocog alfa (1)
- Paricalcitol (1)
- Pegfilgrastim (1)
- Penicillamine (1)
- Phosphate (1)
- Phytomenadione (1)
- Plerixafor (1)
- Polysaccharide-iron complex (1)
- Potassium chloride (1)
- Pyridoxine (1)
- Ravulizumab (1)
- Riboflavin (1)
- Rivaroxaban (2)
- Romiplostim (1)
- Rurioctocog alfa pegol (1)
- Selenium (1)
- Sevelamer (1)
- Simoctocog alfa (1)
- Simvastatin + Ezetimibe (1)
- Sodium bicarbonate (1)
- Sodium chloride (1)
- Sodium phenylbutyrate (1)
- Thiamine (1)
- Tinzaparin (4)
- Trientine (1)
- Turoctocog alfa (2)
- Velaglucerase alfa (1)
- Warfarin (1)
- Zinc (1)
- Zinc acetate (1)
- von Willebrand factor (1)
Planning (87)
- Biosimilars (2)
- New Medicines (69)
  - CCG commissioned new medicines (10)
  - NHS England commissioned new medicines (53)
  - Pre-registration new medicines (UK/EU) (10)
- Patent expiries (35)
Publications (2)
- Bulletins (1)
- Newsletters (1)
- Summary advice (1)
Specialty (148)
- Allergy and immunology (2)
- Cancers (3)
- Cardiovascular system disorders (7)
- Ear, nose and throat disorders (2)
- Eyes and vision (5)
- Gastrointestinal disorders (2)
- Haematological disorders (148)
- Infection and infectious diseases (1)
- Musculo-skeletal disorders (3)
- Nutritional and metabolic disorders (47)
- Obstetrics and gynaecology (1)
- Renal and urologic disorders (7)
- Respiratory disorders (2)
- Skin disorders (4)
- Surgery (3)
- Travel Medicine (1)

How should severe vitamin B12 deficiency in pregnancy be managed?

17 June 2020This updated Medicines Q&A evaluates the limited evidence available on the management of severe vitamin B12 deficiency in pregnancy

Can epoetin be used in Jehovah’s Witness patients in accordance with their beliefs?

5 September 2018On the basis of biblical statements, Jehovah’s Witnesses decline the transfusion of whole blood, red cells, white cells, plasma and platelets. This Medicines Q&A discusses…